Page last updated: 2024-08-22

gadolinium and Kidney Diseases

gadolinium has been researched along with Kidney Diseases in 136 studies

Research

Studies (136)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.47)18.7374
1990's11 (8.09)18.2507
2000's78 (57.35)29.6817
2010's37 (27.21)24.3611
2020's8 (5.88)2.80

Authors

AuthorsStudies
Bu, S; Cao, Q; Ren, W; Wang, G; Xu, L; Zheng, H1
Aaseth, JO; Blomqvist, L; Nordberg, GF; Nurchi, VM1
Baldelomar, EJ; Bennett, KM; Charlton, JR1
Adams, W; El-Bulbul, J; Goldberg, A; Jawahar, A; Joyce, C; Yacoub, J1
Cheng, J; Coulthard, A; Sharma, P1
Dargan, PI; Layne, KA; Wood, DM1
Bruno, F; DeAguero, J; Do, C; Escobar, GP; Lee, DY; Tan, C; Wagner, B1
Borja, MJ; Dogra, S; Lui, YW1
Wagner, B1
Callahan, MJ; Iyer, RS; Lee, JJ; Maloney, E; Menon, S; Phillips, GS1
Do, C; Escobar, P; Ford, B; Lee, DY; Tan, C; Wagner, B1
Hiremath, S; Hurrell, C; Maralani, PJ; Schieda, N; Tsampalieros, AK1
Duan, SB; Liu, GL; Pan, P; Yu, ZQ1
Azar, SF; Chong, S; Elsayes, KM; Hussain, HK; Kappil, M; Liu, PS; Ruma, JA; Willatt, JM1
Calles Blanco, C; Carrasco Muñoz, S; Fernández Álvarez, C; Lafuente Martínez, J; Marcin, J1
Higaki, A; Ito, K; Kanki, A; Nishimura, H; Noda, Y; Sato, T; Tamada, T; Watanabe, S; Yamamoto, A1
Boulanger, T; Carsin-Nicole, B; Delmaire, C; Dhermain, F; Gerber, S; Le Rhun, E; Météllus, P; Petyt, G; Savatovsky, J1
Choi, JW; Rose, TA1
Åslund, PE; Nyman, RS; Nyman, UR; Swanberg, J1
Fukusato, T; Furui, S; Haruyama, T; Kanda, T; Kitajima, K; Kotoku, J; Matsuda, M; Oba, H; Toyoda, K1
Canale, D; de Bragança, AC; Girardi, AC; Gois, PH; Luchi, WM; Seguro, AC; Shimizu, MH; Volpini, RA1
Chen, W; Liang, C; Liang, L; Zhang, B; Zhang, S1
Sato, T1
Agris, J; Endrikat, J; Pietsch, H; Sieber, MA1
Arai, Y; Awai, K; Fukuda, K; Hayakawa, K; Hayashi, H; Ishiguchi, T; Kanematsu, M; Korogi, Y; Kuwatsuru, R; Murakami, T; Narumi, Y; Sugimoto, H; Takagi, R; Takehara, Y; Tsushima, Y; Yoshimitsu, K1
Barbieri, S; Froehlich, JM; Pasch, A; Schroeder, C; Thoeny, HC1
Costello, JR; Kalb, B; Martin, DR1
Martin, DR3
Altenburg, A; Borrmann, M; Grebe, SO; Haage, P; Hein, D; Wesselman, U1
Thomsen, HS1
Chen, MM; Coakley, FV; Kaimal, A; Laros, RK1
Pratt, RD; Smyth, MD1
Morcos, SK; Thomsen, HS1
Perazella, MA4
Halvorsen, RA1
Weinreb, JC1
Edelman, RD; Hamilton, BE; Jacobs, PM; Neuwelt, EA; Rooney, WR; Varallyay, CG; Watnick, SG1
Alam, MU; Alexander, MY; Canfield, AE; Kirton, JP; Martin, D; Riccardi, D; Rouhi, M; Sage, AP; Sinha, S; Towers, E; Vizard, TN; Ward, DT; Wilkinson, FL1
Agarwal, R; Brunelli, SM; Feldman, HI; Mitchell, MD; Umscheid, CA; Williams, K1
Fukuda, K; Hayashi, H; Horio, M; Hosoya, T; Ohno, I; Okada, H; Sugimoto, H; Tamura, S; Tsushima, Y1
Bardin, T; Richette, P1
Buckley, DL; Chrysochou, C; Cowie, A; Dark, P; Kalra, PA1
Jopp, HA1
Cattanéo, A; Goullé, JP; Guerbet, M; Lacroix, C; Mahieu, L; Saussereau, E1
Cianciulli, P; D'Ascola, D; Favilli, B; Filosa, A; Lombardi, M; Meloni, A; Pepe, A; Positano, V; Quarta, A; Restaino, G1
Breitschaft, A; Stahlmann, R1
Fukuda, K; Hayashi, H; Horio, M; Hosoya, T; Korogi, Y; Ohno, I; Okada, H; Sugimoto, H; Tamura, S; Tsushima, Y; Yoshifumi, N1
Berber, I; Cetinel, S; Eren, PA; Kara, M; Krand, O; Sehirli, O; Sener, G; Tellioglu, G; Titiz, I; Yildar, M1
Chrysochou, C; Husain, S; Kalra, PA; Lay, J; Moser, S; Power, A; Salama, AD; Shurrab, AE1
Chang, HJ1
Altmeyer, P; Becker, S; Daul, A; Hillen, U; Kreuter, A; Kribben, A; Napieralski, D; Rump, LC; Schieren, G; Walter, S; Wilde, B; Witzke, O1
Frøkiaer, J; Jørgensen, B; Jørgensen, TM; Karstoft, K; Pedersen, M; Rittig, S1
Fonda, JR; Gagnon, D; Kaufman, JS; Kim, KH; Lawler, EV1
Agarwal, SK; Rees, O1
Bulman, J; Klemm, B; Pandharipande, PV; Pedrosa, I; Rofsky, NM; Sena, BF; Stern, JP1
Pugliese, F1
Duncan, LM; Kagan, A; Kay, J; Mandal, RV; Nazarian, RM1
Manjunath, V; Perazella, MA1
Abu-Alfa, AK1
Britten, A; Craig, AJ; Heenan, SD; Irwin, AG1
Li, S; Lundervold, A; Merrem, AD; Peng, Y; Roervik, J; Schad, LR; Zöllner, FG1
Chien, CC; Chien, TW; Kan, WC; Lin, CY; Su, SB; Wang, HY; Wang, JJ1
Gulani, V; Nicholas, BA; Passalacqua, M; Ponsky, LE; Smith, M; Vricella, GJ1
Nadolski, GJ; Stavropoulos, SW1
Bianco, CC; Brinkman, WT; Bush, RL; Gunnoud, AB; Lin, PH; Lumsden, AB; Martin, LG; Terramani, TT; Weiss, VJ1
Almén, T; Elmståhl, B; Golman, K; Leander, P; Nilsson, M; Nyman, U1
Almèn, T; Morcos, SK; Thomsen, HS1
Morcos, SK2
Brinker, J1
Almén, T; Chai, CM; Elmståhl, B; Frennby, B; Leander, P; Nyman, U1
Buckley, DL; Cheung, CM; Hegarty, J; Kalra, PA; Mamtora, H; Middleton, RJ; Shurrab, AE1
Bettmann, M; Biguori, C; Briguori, C; Solomon, R1
Dacher, JN; Dolores, M; Gardin, I; Lefort, C; Marouteau-Pasquier, N; Vera, P; Vivier, PH1
Gerardin, E; Hervé, F; Lahaxe, L; Levesque, H; Marie, I; Robaday, S1
Israel, GM1
Grenier, N; Hauger, O; Pedersen, M1
Finsterer, J; Stöllberger, C1
Dharnidharka, VR; Fennell, RS; Wesson, SK1
Mitka, M1
Adusumilli, S; Carlos, RC; Ergen, FB; Francis, IR; Hussain, HK; Johnson, TD; Korobkin, M; Weadock, WJ1
Abdel-Rahman, MM; Abdel-Zaher, AO; Hafez, MM; Omran, FM1
Heaf, JG; Marckmann, P; Rossen, K; Skov, L; Thomsen, HS1
Heinrich, M; Uder, M1
Collidge, TA; Mark, PB; Thomson, PC; Traynor, JP1
Perazella, MA; Rodby, RA1
Bukhari, R; Mousa, D1
Abraham, JL; Alhariri, J; Thakral, C1
Nagy, J; Pintér, I; Vágási, K; Wittmann, I1
Cheng, S; Saab, G1
Logager, VB; Marckmann, P; Thomsen, HS1
Chibnik, LB; Kagan, A; Kay, J; Todd, DJ1
Bucala, R; Cowper, SE; Kuo, PH1
Aime, S; Canavese, C; Stratta, P2
Penfield, JG; Reilly, RF1
Matsuo, S; Shimizu, H; Tanaka, A1
Abraham, JL; Helm, TN; Kalb, RE; Kanal, E; Sperry, H; Thakral, C1
Abu-Alfa, A1
Reilly, RF1
Boehm, I1
Cowper, SE; Girardi, M; Rabach, M1
Bilecen, D; Bongartz, G; Mayr, M1
Marckmann, P; Thomsen, HS2
Abu-Alfa, A; Saab, G1
Bellin, MF; Van Der Molen, AJ1
Chan, LP; Kei, PL1
Stenver, DI1
Broome, DR1
Cowper, SE1
Brown, HH; Hiatt, K; High, WA; Horn, TD; Ranville, J; Shah, SV; Swaminathan, S; Thomas, M1
Frenzel, T; Lengsfeld, P; Pietsch, H; Schirmer, H; Sieber, MA; Siegmund, F; Walter, J; Weinmann, HJ1
Bhandari, M; Gujral, RB; Gupta, RK; Pandey, CM; Poptani, H; Sharma, RK1
Brown, ED; Semelka, RC1
Gibson, RJ; Meanock, CI; Torrie, EP; Walker, TM1
Debatin, JF; Huch Böni, RA; Krestin, GP1
Berg, KJ; Lundby, B; Nordal, KP; Reinton, V; Rootwelt, K; Smith, HJ1
Knesplova, L; Krestin, GP1
Ascher, SM; Hewes, LB; Patt, RH1
Bakker, J; Beek, FJ; Hené, RJ; Ligtenberg, G; van Reedt Dortland, RW1
Bigot, JM; Farres, MT; Flahault, A; Gattegno, B; Paula-Souza, R; Ronco, P1
Adam, GB; Günther, RW; Hübner, D; Nolte-Ernsting, CC; Rohrmann, D; Staatz, G; Stollbrink, C1
Becerra, CR; Carbone, DP; Frenkel, EP; Rosenthal, DI; Toto, RD1
Linsenmaier, U; Pfeifer, KJ; Rieger, J; Schiffl, H; Sitter, T; Toepfer, M1
Bernreuter, WK; Kenney, PJ; Listinsky, JJ; Morgan, DE; Rominger, MB1
Austin, HA; Choyke, PL; Frank, JA; Girton, ME1
Choyke, PL; Diggs, R; Frank, JA; Girton, ME; Morrison, P; Skinner, M1
Beyer, HK; Rühl, G; Uhlenbrock, D1
Felix, R; Fiegler, W; Köhler, D; Schörner, W1

Reviews

46 review(s) available for gadolinium and Kidney Diseases

ArticleYear
Gadolinium in Medical Imaging-Usefulness, Toxic Reactions and Possible Countermeasures-A Review.
    Biomolecules, 2022, 05-24, Volume: 12, Issue:6

    Topics: Chelating Agents; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging

2022
Where does the gadolinium go? A review into the excretion and retention of intravenous gadolinium.
    Journal of medical imaging and radiation oncology, 2023, Volume: 67, Issue:7

    Topics: Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy

2023
Gadolinium-based contrast agents - what is the evidence for 'gadolinium deposition disease' and the use of chelation therapy?
    Clinical toxicology (Philadelphia, Pa.), 2020, Volume: 58, Issue:3

    Topics: Chelation Therapy; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Treatment Outcome

2020
Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.
    Pediatric radiology, 2019, Volume: 49, Issue:4

    Topics: Child; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Injections, Intravenous; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Premedication; Risk Assessment; Risk Factors; Surveys and Questionnaires

2019
[Brain metastases imaging].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2015, Volume: 19, Issue:1

    Topics: Brain Neoplasms; Carbon Radioisotopes; Carcinoma; Clinical Protocols; Contrast Media; Diagnostic Imaging; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Melanoma; Methionine; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed

2015
Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know.
    The American journal of medicine, 2015, Volume: 128, Issue:9

    Topics: Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Fibrosis; Gadolinium; Humans; Hypersensitivity, Immediate; Hypoglycemic Agents; Injections, Intravenous; Iodine Radioisotopes; Kidney; Kidney Diseases; Metformin; Radioisotopes

2015
Incidence and Risk Factors for Gadolinium-Based Contrast Agent Immediate Reactions.
    Topics in magnetic resonance imaging : TMRI, 2016, Volume: 25, Issue:6

    Topics: Chelating Agents; Contrast Media; Drug Hypersensitivity; Evidence-Based Medicine; Gadolinium; Humans; Incidence; Internationality; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Survival Rate

2016
Nephrogenic systemic fibrosis: more questions and some answers.
    Nephron. Clinical practice, 2008, Volume: 110, Issue:1

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin; Skin Diseases

2008
Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis.
    Current drug safety, 2008, Volume: 3, Issue:1

    Topics: Animals; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging

2008
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
    Kidney international, 2009, Volume: 75, Issue:5

    Topics: Central Nervous System; Chronic Disease; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Glomerular Filtration Rate; Humans; Iron; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Nanoparticles; Nephrogenic Fibrosing Dermopathy; Oxides; Risk Factors

2009
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:3

    Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Dialysis

2009
Rheumatic manifestations of renal disease.
    Current opinion in rheumatology, 2009, Volume: 21, Issue:1

    Topics: Calcinosis; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Contrast Media; Gadolinium; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Rheumatic Diseases

2009
Current status of gadolinium toxicity in patients with kidney disease.
    Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:2

    Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Evidence-Based Medicine; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors

2009
Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience.
    Journal of magnetic resonance imaging : JMRI, 2009, Volume: 29, Issue:4

    Topics: Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver Diseases; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Prognosis; United Kingdom

2009
Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm.
    Current opinion in nephrology and hypertension, 2009, Volume: 18, Issue:6

    Topics: Acute Disease; Animals; Chronic Disease; Contrast Media; Disease Models, Animal; Disease Progression; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Risk Assessment; Risk Factors

2009
MRI gadolinium-based contrast agents. Radiologists beware!
    Annales pharmaceutiques francaises, 2009, Volume: 67, Issue:5

    Topics: Chelating Agents; Contrast Media; Fibrosis; France; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging

2009
[Nephrogenic systemic fibrosis].
    Medizinische Monatsschrift fur Pharmazeuten, 2009, Volume: 32, Issue:10

    Topics: Contrast Media; Fibrosis; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Skin Diseases

2009
Imaging patients with kidney disease in the era of NSF: can it be done safely?
    Clinical nephrology, 2011, Volume: 75, Issue:4

    Topics: Contrast Media; Diagnostic Imaging; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Risk Factors

2011
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
    Advances in chronic kidney disease, 2011, Volume: 18, Issue:3

    Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors

2011
Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk.
    The Canadian journal of urology, 2012, Volume: 19, Issue:1

    Topics: Algorithms; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Radiographic Image Enhancement; Risk Factors; Tomography, X-Ray Computed

2012
Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations.
    Journal of vascular surgery, 2013, Volume: 57, Issue:2

    Topics: Angiography; Carbon Dioxide; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Iodine; Kidney; Kidney Diseases; Radiography, Interventional; Risk Assessment; Risk Factors

2013
Selection of contrast media.
    Kidney international. Supplement, 2006, Issue:100

    Topics: Contrast Media; Gadolinium; Humans; Iodine; Kidney Diseases; Molecular Structure; Osmolar Concentration; Radiopharmaceuticals; Randomized Controlled Trials as Topic; X-Rays

2006
Intravenous immunoglobulin-associated cranial pachymeningitis.
    Journal of internal medicine, 2006, Volume: 260, Issue:2

    Topics: Adult; Dura Mater; Gadolinium; Humans; Immunoglobulins, Intravenous; Kidney Diseases; Magnetic Resonance Imaging; Male; Meningitis, Aseptic; Polyarteritis Nodosa; Radioisotopes; Tomography, X-Ray Computed

2006
MRI of the kidney and urinary tract.
    Journal of magnetic resonance imaging : JMRI, 2006, Volume: 24, Issue:4

    Topics: Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Image Processing, Computer-Assisted; Kidney Diseases; Magnetic Resonance Imaging; Urologic Diseases

2006
Contrast agents for functional and cellular MRI of the kidney.
    European journal of radiology, 2006, Volume: 60, Issue:3

    Topics: Contrast Media; Ferric Compounds; Gadolinium; Glomerular Filtration Rate; Humans; Image Processing, Computer-Assisted; Kidney Diseases; Kidney Tubules; Magnetic Resonance Imaging; Organometallic Compounds; Renal Circulation

2006
[Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2007, Volume: 179, Issue:6

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases

2007
[Nephrogenic systemic fibrosis].
    Orvosi hetilap, 2007, Sep-23, Volume: 148, Issue:38

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Kidney Transplantation; Magnetic Resonance Imaging; Photopheresis; Plasmapheresis; Renal Dialysis; Skin; Skin Diseases

2007
Nephrogenic systemic fibrosis: a nephrologist's perspective.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2007, Volume: 11 Suppl 3

    Topics: Contrast Media; Decision Making; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Renal Insufficiency; Risk Factors

2007
What nephrologists need to know about gadolinium.
    Nature clinical practice. Nephrology, 2007, Volume: 3, Issue:12

    Topics: Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrology

2007
[Drug-induced nephropathy].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8

    Topics: Aminoglycosides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Contrast Media; Creatinine; Fibrosis; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Tubular Necrosis, Acute; Metabolic Clearance Rate

2007
The impact of NSF on the care of patients with kidney disease.
    Journal of the American College of Radiology : JACR, 2008, Volume: 5, Issue:1

    Topics: Acidosis; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin; Skin Diseases

2008
Nephrogenic system fibrosis: a radiologist's practical perspective.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Contrast Media; Documentation; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Humans; Informed Consent; Kidney Diseases; Magnetic Resonance Imaging; Renal Dialysis; Risk Factors; Skin Diseases

2008
Clinical and histological findings in nephrogenic systemic fibrosis.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Contrast Media; Diagnosis, Differential; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases

2008
Magnetic resonance angiography (MRA) in renally impaired patients: when and how.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Contrast Media; Decision Making; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Angiography; Skin Diseases

2008
Extracellular Gd-CA: differences in prevalence of NSF.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Contrast Media; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Imaging; Prevalence; Registries; Skin Diseases

2008
Nephrogenic systemic fibrosis--implications for nephrologists.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin Diseases

2008
Extracellular gadolinium contrast agents: differences in stability.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Contrast Media; Drug Stability; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases

2008
Extracellular gadolinium-based contrast media: an overview.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Image Enhancement; Kidney Diseases; Magnetic Resonance Imaging; Osmolar Concentration; Skin Diseases; Teratogens; Viscosity

2008
Pharmacovigilance: what to do if you see an adverse reaction and the consequences.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Product Surveillance, Postmarketing; Skin Diseases

2008
Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Organ Specificity; Risk Factors; Skin Diseases

2008
Gadolinium - is it to blame?
    Journal of cutaneous pathology, 2008, Volume: 35, Issue:5

    Topics: Contrast Media; Dermatology; Fibrosis; Gadolinium; Humans; Kidney Diseases; Pathology; Risk Assessment

2008
Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
    Current medicinal chemistry, 2008, Volume: 15, Issue:12

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Renal Dialysis; Renal Insufficiency; Risk; Skin Diseases

2008
Contrast-enhanced magnetic resonance imaging of the abdomen.
    Magnetic resonance quarterly, 1994, Volume: 10, Issue:2

    Topics: Abdomen; Contrast Media; Gadolinium; Gastrointestinal Diseases; Humans; Image Enhancement; Kidney Diseases; Liver Diseases; Magnetic Resonance Imaging; Pancreatic Diseases

1994
Contrast-enhanced MR imaging of the kidneys and adrenal glands.
    Magnetic resonance imaging clinics of North America, 1996, Volume: 4, Issue:1

    Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid

1996
Magnetic resonance in the assessment of renal function.
    European radiology, 1998, Volume: 8, Issue:2

    Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Magnetic Resonance Imaging; Microcirculation; Renal Circulation

1998
Kidneys: combining morphology and function.
    Diagnostic imaging, 1993, Volume: 15 Suppl

    Topics: Contrast Media; Gadolinium; Humans; Image Enhancement; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Pentetic Acid

1993

Trials

5 trial(s) available for gadolinium and Kidney Diseases

ArticleYear
A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents.
    Renal failure, 2022, Volume: 44, Issue:1

    Topics: Albumins; Blood Glucose; Contrast Media; Female; Furosemide; Gadolinium; Humans; Kidney Diseases; Male; Retrospective Studies; Risk Factors; ROC Curve

2022
Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies.
    Haematologica, 2009, Volume: 94, Issue:11

    Topics: Adolescent; Adult; Child; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Hemoglobinopathies; Humans; Kidney Diseases; Male; Young Adult

2009
Preoperative evaluation of living renal donors with gadolinium-enhanced magnetic resonance angiography.
    Transplantation, 1999, Apr-27, Volume: 67, Issue:8

    Topics: Adult; Aged; Angiography, Digital Subtraction; Female; Gadolinium; Humans; Image Enhancement; Kidney Diseases; Kidney Transplantation; Living Donors; Magnetic Resonance Angiography; Male; Middle Aged; Nephrectomy

1999
Nonnephrotoxic, dynamic, contrast enhanced magnetic resonance urography: use in nephrology and urology.
    The Journal of urology, 2000, Volume: 163, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Female; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Urography; Urologic Diseases

2000
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin.
    American journal of clinical oncology, 2000, Volume: 23, Issue:6

    Topics: Adult; Biomarkers; Dose-Response Relationship, Drug; Female; Gadolinium; Humans; Kidney Diseases; Male; Metalloporphyrins; Middle Aged; Neoplasms; Palliative Care; Radiation-Sensitizing Agents

2000

Other Studies

85 other study(ies) available for gadolinium and Kidney Diseases

ArticleYear
Mapping single-nephron filtration in the isolated, perfused rat kidney using magnetic resonance imaging.
    American journal of physiology. Renal physiology, 2022, 11-01, Volume: 323, Issue:5

    Topics: Animals; Gadolinium; Glomerular Filtration Rate; Kidney; Kidney Diseases; Kidney Glomerulus; Magnetic Resonance Imaging; Nephrons; Rats

2022
Safety profile of Gadoterate meglumine on the renal function of patients with severe kidney disease.
    Clinical imaging, 2022, Volume: 91

    Topics: Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies

2022
Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis.
    American journal of physiology. Renal physiology, 2021, 04-01, Volume: 320, Issue:4

    Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Fibrosis; Gadolinium; Kidney; Kidney Diseases; Mice; NADPH Oxidase 4; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency

2021
Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.
    AJNR. American journal of neuroradiology, 2021, Volume: 42, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System; Cerebellar Nuclei; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pons; Retrospective Studies; Young Adult

2021
Scared to the Marrow: Pitfalls and Pearls in Renal Imaging.
    Advances in chronic kidney disease, 2017, Volume: 24, Issue:3

    Topics: Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals

2017
Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors.
    Toxicology and applied pharmacology, 2019, 07-15, Volume: 375

    Topics: Animals; Bone Marrow Transplantation; Contrast Media; Diet, High-Fat; Female; Fibrosis; Gadolinium; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Nephrectomy; Random Allocation

2019
Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists.
    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2019, Volume: 70, Issue:3

    Topics: Canada; Contrast Media; Gadolinium; Humans; Image Enhancement; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Radiologists; Societies, Medical

2019
Urinary KIM-1, IL-18 and Cys-c as early predictive biomarkers in gadolinium-based contrast-induced nephropathy in the elderly patients.
    Clinical nephrology, 2013, Volume: 80, Issue:5

    Topics: Aged; Biomarkers; Contrast Media; Creatinine; Cystatin C; Female; Gadolinium; Hepatitis A Virus Cellular Receptor 1; Humans; Interleukin-18; Kidney Diseases; Male; Membrane Glycoproteins; Middle Aged; Receptors, Virus

2013
MR imaging in the characterization of small renal masses.
    Abdominal imaging, 2014, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult

2014
[Gadolinium-based contrast agents for magnetic resonance imaging].
    Radiologia, 2014, Volume: 56 Suppl 1

    Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors

2014
Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    La Radiologia medica, 2015, Volume: 120, Issue:6

    Topics: Animals; Carbon Tetrachloride Poisoning; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Cirrhosis; Liver Diseases; Male; Mass Spectrometry; Nephrectomy; Rats; Rats, Wistar

2015
Ultra-low iodine concentrations iso-attenuating with diagnostic 0.5M gadolinium in endovascular procedures to minimize the risk of contrast nephropathy: A phantom study.
    European journal of radiology, 2015, Volume: 84, Issue:6

    Topics: Angiography; Contrast Media; Endovascular Procedures; Female; Fluoroscopy; Gadolinium; Humans; Iodine; Kidney Diseases; Male; Middle Aged; Phantoms, Imaging; Radiation Dosage; Tomography, X-Ray Computed

2015
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.
    Radiology, 2015, Volume: 276, Issue:1

    Topics: Autopsy; Brain; Contrast Media; Gadolinium; Humans; Kidney Diseases; Severity of Illness Index; Spectrophotometry, Atomic; Tissue Distribution

2015
Vitamin D deficiency is a potential risk factor for contrast-induced nephropathy.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2015, Aug-01, Volume: 309, Issue:3

    Topics: Animals; Contrast Media; Diabetic Nephropathies; Disease Models, Animal; Gadolinium; Kidney; Kidney Diseases; Male; Oxidative Stress; Rats, Wistar; Risk Factors; Vitamin D; Vitamin D Deficiency

2015
An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Meta-Analysis as Topic; Nephrogenic Fibrosing Dermopathy; Risk Factors

2015
Response to the Comments by Dr. Endrikat et al. on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Sh
    La Radiologia medica, 2016, Volume: 121, Issue:3

    Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Diseases; Male

2016
Comments on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Shigeru Watanabe et al. DOI 10.1007/s1154
    La Radiologia medica, 2016, Volume: 121, Issue:3

    Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Diseases; Male

2016
Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey.
    Japanese journal of radiology, 2016, Volume: 34, Issue:2

    Topics: Breast Feeding; Contrast Media; Female; Gadolinium; Humans; Iodine; Japan; Kidney Diseases; Kidney Function Tests; Male; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Pregnancy; Risk Factors; Surveys and Questionnaires

2016
High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.
    Contrast media & molecular imaging, 2016, Volume: 11, Issue:3

    Topics: Aged; Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Globus Pallidus; Humans; Kidney Diseases; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Vascular Calcification

2016
Introduction.
    Topics in magnetic resonance imaging : TMRI, 2016, Volume: 25, Issue:6

    Topics: Chelating Agents; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging

2016
Chronic inflammation and accelerated atherosclerosis as important cofactors in nephrogenic systemic fibrosis following intravenous gadolinium exposure.
    Clinical and experimental nephrology, 2008, Volume: 12, Issue:5

    Topics: Atherosclerosis; Chronic Disease; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Inflammation; Kidney Diseases; Middle Aged; Time Factors

2008
Is NSF only the tip of the "gadolinium toxicity" iceberg?
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 28, Issue:2

    Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases

2008
Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation.
    Obstetrics and gynecology, 2008, Volume: 112, Issue:2 Pt 1

    Topics: Abnormalities, Radiation-Induced; Acute Disease; Adult; Appendicitis; Cephalopelvic Disproportion; Colic; Contrast Media; Female; Fetus; Gadolinium; Humans; Kidney Diseases; Lactation; Magnetic Resonance Imaging; Obstetrics; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Radiation Dosage; Tomography, X-Ray Computed

2008
Letter regarding 'Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate'.
    Kidney international, 2008, Volume: 74, Issue:4

    Topics: Chelating Agents; Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; United States; United States Food and Drug Administration; Uremia

2008
Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging.
    Radiology, 2008, Volume: 249, Issue:1

    Topics: Anaphylaxis; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Hypersensitivity; Iodine; Kidney Diseases; Magnetic Resonance Imaging; Maternal-Fetal Exchange; Pregnancy; Tomography, X-Ray Computed

2008
Which study when? Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT?
    Radiology, 2008, Volume: 249, Issue:1

    Topics: Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Female; Fetus; Fibrosis; Gadolinium; Humans; Iodine; Kidney Diseases; Magnetic Resonance Imaging; Pregnancy; Tomography, X-Ray Computed

2008
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells.
    Cardiovascular research, 2009, Feb-01, Volume: 81, Issue:2

    Topics: Aniline Compounds; Animals; Calcinosis; Calcium; Cattle; Cells, Cultured; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Gadolinium; Humans; Kidney Diseases; Minerals; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenethylamines; Phosphorylation; Propylamines; Receptors, Calcium-Sensing

2009
[Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction].
    Nihon Jinzo Gakkai shi, 2008, Volume: 50, Issue:7

    Topics: Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Nephrogenic Fibrosing Dermopathy

2008
[How safe are gadolinium-based contrast media? Nominal ranges for usage?].
    Der Radiologe, 2009, Volume: 49, Issue:4

    Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Humans; Kidney Diseases

2009
[Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction--second edition].
    Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:7

    Topics: Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy

2009
Evaluation of gadolinium pre-treatment with or without splenectomy in the setting of renal ischemia reperfusion injury in rats.
    Renal failure, 2009, Volume: 31, Issue:10

    Topics: Animals; Gadolinium; Kidney Diseases; Male; Rats; Rats, Wistar; Reperfusion Injury; Splenectomy

2009
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
    Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:3

    Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors

2010
Researchers focus on contrast safety.
    JAMA, 2010, Apr-07, Volume: 303, Issue:13

    Topics: Animals; Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Rats; Tomography, X-Ray Computed

2010
The German registry for nephrogenic systemic fibrosis: findings from 23 patients.
    Clinical nephrology, 2010, Volume: 73, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Germany; Humans; Kidney Diseases; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Registries; Risk Factors

2010
Structural and functional MRI in children with renal disease: first experience.
    Zeitschrift fur medizinische Physik, 2010, Volume: 20, Issue:2

    Topics: Adolescent; Algorithms; Child; Child, Preschool; Edetic Acid; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Male

2010
Change in use of gadolinium-enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration warnings: a cross-sectional study of Veterans Affairs Health Care System data from 2005-2008.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 56, Issue:3

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Contrast Media; Creatinine; Cross-Sectional Studies; Databases, Factual; Drug Utilization; Female; Gadolinium; Glomerular Filtration Rate; Guideline Adherence; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; United States; United States Department of Veterans Affairs; United States Food and Drug Administration; Young Adult

2010
Nephrogenic systemic fibrosis: UK survey of the use of gadolinium-based contrast media.
    Clinical radiology, 2010, Volume: 65, Issue:8

    Topics: Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Guideline Adherence; Humans; Kidney Diseases; Magnetic Resonance Angiography; Male; National Health Programs; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Prognosis; Risk Assessment; Surveys and Questionnaires; United Kingdom

2010
Screening patients to assess renal function before administering gadolinium chelates: assessment of the Choyke questionnaire.
    AJR. American journal of roentgenology, 2010, Volume: 195, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Boston; Chelating Agents; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Male; Mass Screening; Middle Aged; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires; Young Adult

2010
Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 56, Issue:3

    Topics: Adverse Drug Reaction Reporting Systems; Chronic Disease; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Patterns, Physicians'; United States; United States Food and Drug Administration

2010
Gadolinium-enhanced coronary CT angiography: improved safety?
    Heart (British Cardiac Society), 2010, Volume: 96, Issue:19

    Topics: Contrast Media; Coronary Angiography; Gadolinium; Humans; Iodine Compounds; Kidney Diseases; Tomography, X-Ray Computed

2010
Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.
    Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:4

    Topics: Adult; Aged; Biopsy; Cell Count; Contrast Media; Creatinine; Dermis; Female; Gadolinium; Humans; Kidney Diseases; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies

2011
Significant differences when using MDRD for GFR estimation compared to radionuclide measured clearance.
    European radiology, 2011, Volume: 21, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Chromium Radioisotopes; Creatinine; Diet; Edetic Acid; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Regression Analysis; Reproducibility of Results; Retrospective Studies

2011
Wavelet-based segmentation of renal compartments in DCE-MRI of human kidney: initial results in patients and healthy volunteers.
    Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, 2012, Volume: 36, Issue:2

    Topics: Algorithms; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Wavelet Analysis

2012
Risk of acute kidney injury after exposure to gadolinium-based contrast in patients with renal impairment.
    Renal failure, 2011, Volume: 33, Issue:8

    Topics: Acute Kidney Injury; Aged; Contrast Media; Female; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Risk Factors

2011
Endovascular aortic aneurysm repair in patients with renal dysfunction or severe contrast allergy: utility of imaging modalities without iodinated contrast.
    Annals of vascular surgery, 2002, Volume: 16, Issue:5

    Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Aortic Rupture; Combined Modality Therapy; Contrast Media; Creatinine; Drug Hypersensitivity; Female; Follow-Up Studies; Gadolinium; Georgia; Humans; Incidence; Iodine; Kidney Diseases; Magnetic Resonance Angiography; Male; Radiographic Image Enhancement; Renal Dialysis; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional; Vascular Surgical Procedures

2002
Gadolinium contrast media for DSA in azotemia: are they really safer than iodinated agents?
    Academic radiology, 2002, Volume: 9 Suppl 2

    Topics: Angiography, Digital Subtraction; Animals; Contrast Media; Gadolinium; Humans; Iodine; Kidney Diseases; Mice; Osmolar Concentration; Rats; Uremia

2002
Gadolinium-containing contrast media for radiographic examinations: a position paper.
    European radiology, 2002, Volume: 12, Issue:10

    Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Lethal Dose 50; Rabbits; Radiography; Swine

2002
Contrast nephrotoxicity and iso-osmolar contrast agents: implications of nephric.
    Clinical radiology, 2004, Volume: 59, Issue:3

    Topics: Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Osmolar Concentration

2004
Sometimes less is just less.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 63, Issue:3

    Topics: Coronary Angiography; Gadolinium; Humans; Kidney Diseases; Organometallic Compounds

2004
Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs.
    Academic radiology, 2004, Volume: 11, Issue:11

    Topics: Angiography; Animals; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Gadolinium; Half-Life; Image Processing, Computer-Assisted; Injections, Intra-Arterial; Iodine; Kidney; Kidney Diseases; Male; Osmolar Concentration; Swine; Time Factors

2004
MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease.
    Kidney international, 2006, Volume: 69, Issue:4

    Topics: Aged; Aged, 80 and over; Atherosclerosis; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Cortex; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Regression Analysis; Renal Artery Obstruction

2006
[Magnetic resonance urography in children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2006, Volume: 13, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Contrast Media; France; Gadolinium; Humans; Hydronephrosis; Image Processing, Computer-Assisted; Infant; Infant, Newborn; Kidney Diseases; Kidney Diseases, Cystic; Kidney Function Tests; Magnetic Resonance Imaging; Syndrome; Ureteral Obstruction; Urodynamics; Urography

2006
Dermal and extra-dermal manifestations of gadolinium-triggered nephrogenic fibrosing dermopathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:12

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Skin; Skin Diseases

2006
Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients.
    Pediatric nephrology (Berlin, Germany), 2007, Volume: 22, Issue:9

    Topics: Child; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Skin; Skin Diseases

2007
MRI contrast agents may pose risk for patients with kidney disease.
    JAMA, 2007, Jan-17, Volume: 297, Issue:3

    Topics: Comorbidity; Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk; Skin Diseases; Syndrome

2007
Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
    MMWR. Morbidity and mortality weekly report, 2007, Feb-23, Volume: 56, Issue:7

    Topics: Case-Control Studies; Comorbidity; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Missouri; Renal Dialysis; Risk Factors; Skin Diseases

2007
3D excretory MR urography: improved image quality with intravenous saline and diuretic administration.
    Journal of magnetic resonance imaging : JMRI, 2007, Volume: 25, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diuretics; Furosemide; Gadolinium; Humans; Imaging, Three-Dimensional; Injections, Intravenous; Kidney Diseases; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Sodium Chloride; Urinary Tract; Urography

2007
Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage.
    Toxicology, 2007, May-05, Volume: 234, Issue:1-2

    Topics: Acetaminophen; Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Creatinine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gadolinium; Glutathione; Guanidines; Injections, Intramuscular; Kidney Diseases; Liver Diseases; Male; Nitric Oxide; Oleanolic Acid; Protective Agents; Rats; Rats, Wistar; Survival Analysis; Survival Rate

2007
Case-control study of gadodiamide-related nephrogenic systemic fibrosis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:11

    Topics: Case-Control Studies; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Reference Values

2007
Gadolinium contrast may be risky in kidney disease.
    BMJ (Clinical research ed.), 2007, Jun-30, Volume: 334, Issue:7608

    Topics: Contrast Media; Fibromyalgia; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Angiography; Organometallic Compounds; Peripheral Vascular Diseases; Risk Factors

2007
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.
    The American journal of medicine, 2007, Volume: 120, Issue:7

    Topics: Fibrosis; Gadolinium; Humans; Kidney Diseases; Radioisotopes; Radiopharmaceuticals; Skin Diseases

2007
Chronic kidney disease and stiff hands.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2007, Volume: 18, Issue:3

    Topics: Adult; Chronic Disease; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Skin

2007
Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.
    Contrast media & molecular imaging, 2007, Volume: 2, Issue:4

    Topics: Adult; Bone and Bones; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin

2007
Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2007, Sep-24, Volume: 7

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Time Factors

2007
Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fibrosis; Follow-Up Studies; Gadolinium; Humans; Kidney Diseases; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Skin; Skin Diseases; Syndrome

2007
Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:10

    Topics: Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Imaging; Radiopharmaceuticals; Skin; Skin Diseases

2007
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate.
    Kidney international, 2007, Volume: 72, Issue:9

    Topics: Chelating Agents; Contraindications; Fibrosis; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; Skin Diseases; United States; United States Food and Drug Administration; Uremia

2007
Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    The British journal of dermatology, 2008, Volume: 158, Issue:3

    Topics: Contrast Media; Fibrosis; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Skin; Skin Diseases; Treatment Outcome

2008
Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis.
    Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:3

    Topics: Aged; Contrast Media; Female; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Hospitals, Veterans; Humans; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Dialysis; Risk Assessment; Skin Diseases; Texas; Time Factors

2008
Nephrogenic systemic fibrosis in patients undergoing hemodialysis: comment on the article by Todd et al.
    Arthritis and rheumatism, 2008, Volume: 58, Issue:3

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Renal Dialysis; Skin Diseases

2008
MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.
    European journal of radiology, 2008, Volume: 66, Issue:2

    Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Image Enhancement; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases

2008
Gadolinium chelate-associated nephrogenic systemic fibrosis.
    Singapore medical journal, 2008, Volume: 49, Issue:3

    Topics: Contrast Media; Creatinine; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Scleroderma, Systemic; Singapore; Skin; Skin Diseases

2008
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?
    Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:3

    Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Patient Selection; Renal Dialysis; Risk Assessment; Skin Diseases; Time Factors

2008
Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis.
    Kidney international, 2008, Volume: 73, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Autopsy; Blood Vessels; Cardiovascular Diseases; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Kidney Diseases; Liver; Male; Middle Aged; Myocardium; Skin; Tissue Distribution

2008
Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand.
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 27, Issue:5

    Topics: Animals; Contrast Media; Copper; Fibrosis; Gadolinium; Gadolinium DTPA; Kidney Diseases; Ligands; Male; Organometallic Compounds; Rats; Skin Diseases; Statistics, Nonparametric; Tissue Distribution; Zinc

2008
The magnetic resonance renogram in renal transplant evaluation using dynamic contrast-enhanced MR imaging.
    Transplantation, 1995, May-27, Volume: 59, Issue:10

    Topics: Adult; Biopsy; Contrast Media; Cyclosporine; Female; Gadolinium; Gadolinium DTPA; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Radioisotope Renography; Transplantation, Homologous

1995
An assessment of Gd-DTPA as a CT contrast agent in the renal tract.
    Clinical radiology, 1993, Volume: 47, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed

1993
Gadodiamide in renal transplant patients: effects on renal function and usefulness as a glomerular filtration rate marker.
    Nephron, 1996, Volume: 72, Issue:2

    Topics: Adult; Aged; beta 2-Microglobulin; Biomarkers; Contrast Media; Creatinine; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Half-Life; Humans; Injections, Intravenous; Iodine Radioisotopes; Iothalamic Acid; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1996
Feasibility and utility of respiratory-gated, gadolinium-enhanced T1-weighted magnetic resonance urography in children.
    Investigative radiology, 2000, Volume: 35, Issue:8

    Topics: Adolescent; Age Factors; Child; Child, Preschool; Female; Gadolinium; Humans; Image Enhancement; Infant; Infant, Newborn; Kidney Diseases; Magnetic Resonance Imaging; Male; Respiration; Ureteral Diseases; Urography

2000
Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Contrast Media; Creatinine; Female; Gadolinium; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Safety

2002
Gadolinium-enhanced MR imaging of renal masses.
    Radiographics : a review publication of the Radiological Society of North America, Inc, 1992, Volume: 12, Issue:6

    Topics: Carcinoma, Renal Cell; Contrast Media; Cysts; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Kidney Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid

1992
Functional MR of the kidney.
    Magnetic resonance in medicine, 1991, Volume: 22, Issue:2

    Topics: Animals; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid

1991
Gadopentetate dimeglumine clearance in renal insufficiency in rabbits.
    Investigative radiology, 1990, Volume: 25, Issue:11

    Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Organometallic Compounds; Pentetic Acid; Rabbits

1990
[Importance of contrast medium administration in determining the age of traumatic renal hemorrhage by NMR tomography--experimental results].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1988, Volume: 148, Issue:2

    Topics: Animals; Diagnosis, Differential; Drug Evaluation, Preclinical; Gadolinium; Gadolinium DTPA; Hematoma; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains; Time Factors

1988
[Diagnosis of kidney diseases with magnetic resonance tomography including the use of nuclear magnetic resonance contrast media].
    Der Urologe. Ausg. A, 1985, Volume: 24, Issue:5

    Topics: Diagnosis, Differential; Gadolinium; Humans; Hydronephrosis; Kidney; Kidney Diseases; Kidney Diseases, Cystic; Kidney Neoplasms; Lipoma; Magnetic Resonance Spectroscopy; Nephritis; Pentetic Acid; Tomography, X-Ray Computed

1985